Table 3 Regional sero-prevalence (ages 2–10 years) by antigen and all-age incidence rates for clinical malaria and Pf infection. Mean sero-prevalence (%) and incidence rates with 95% CI shown in parentheses

Clinical incidence rate

0.08 (0.04–0.21)

0.14 (0.04–0.44)

0.13 (0.04–0.39)

0.21 (0.1–0.51)

Pf infection rate

0.23 (0.13–0.39)

0.67 (0.40–1.13)

0.56 (0.42–0.74)

2.87 (2.36–3.50)

n = 205

n = 197

n = 275

n = 324

Etramp5.Ag1

4.4% (1.6–7.2)

13.7% (8.9–18.5)

8.7% (5.4–12.1)

33.3% (27.4–39.3)

GEXP18

11.7% (7.3–16.1)

12.7% (8.0–17.3)

25.1% (20.0–30.2)

36.3% (30.2–42.3)

HSP40.Ag1

5.4% (2.3–8.5)

6.1% (2.8–9.4)

8.4% (5.1–11.6)

23.8% (18.4–29.1)

Rh2.2030

1.0% (0.0–2.3)

1.0% (0.0–2.4)

9.8% (6.3–13.3)

25.4% (19.9–30.9)

EBA175

1.5% (0.0–3.1)

1.0% (0.0–2.4)

7.3% (4.2–10.3)

15.8% (11.2–20.5)

PfMSP1₁₉

2.9% (0.6–5.2)

8.1% (4.3–11.9)

5.1% (2.5–7.7)

22.1% (16.8–27.3)

PfAMA1

4.4% (1.6–7.2)

4.1% (1.3–6.8)

17.8% (13.3–22.3)

33.3% (27.4–39.3)

PfGLURP.R2

4.4% (1.6–7.2)

8.1% (4.3–11.9)

16.4% (12.0–20.7)

30.4% (24.6–36.2)